PDCD1LG2 and neoplasm: Relative expression of PD-L2, compared to PD-L1, is increased in PMBL with more than 70% of tumor cells expressing the ligand and polymerase chain reaction (PCR) testing confirming copy number gains in PD-L2 in these patients [17].